A cost-effective algorithm for hereditary nonpolyposis colorectal cancer detection

被引:15
作者
Bouzourene, H
Taminelli, L
Chaubert, P
Monnerat, C
Seelentag, W
Sandmeier, D
Andrejevic, S
Matter, M
Bosman, F
Benhattar, J
机构
[1] CHU Vaudois, Inst Pathol, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Inst Genet, CH-1011 Lausanne, Switzerland
[3] CHU Vaudois, Dept Surg, CH-1011 Lausanne, Switzerland
关键词
colorectal cancer; microsatellite instability; hereditary nonpolyposis colorectal cancer; HNPCC; immunohistochemistry; hMLH1; methylation;
D O I
10.1309/B0AFDT52ETMKEJBE
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Colorectal cancer with microsatellite instability (MSI) may occur sporadically or be inherited in cases of hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. However, there is no consensus as to which patients must be tested and how, to test MSI. In this study, MS was tested by inummohistochemical analysis and by polymerase chain reaction in 148 cases of colorectal cancer: and methylation of the hMLH1 Promoter was examined. MSI status was correlated with tumor phenotype. We found that localization, tumor infltrating lymphocytes, and mucinous differentiation were predictive of high-frequency MSI (MSI-H) colorectal cancer and might be used to select cases,for MSI analysis. Immunohistochemical analysis detected most MSI-H colorectal cancer and might constitute the first step in MSI detection. Absence of hMLH1 promoter methylation in MSI-H colorectal cancer could be predictive of hereditary colorectal cancer; and, hence, methylation analysis might constitute the second step in the identification of patients with HNPCC.
引用
收藏
页码:823 / 831
页数:9
相关论文
共 47 条
[11]   Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer [J].
Debniak, T ;
Kurzawski, G ;
Gorski, B ;
Kladny, J ;
Domagala, W ;
Lubinski, J .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (01) :49-54
[12]  
Elsaleh H, 2001, GASTROENTEROLOGY, V120, P1309
[13]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[14]  
Fink D, 1998, CLIN CANCER RES, V4, P1
[15]   THE HUMAN MUTATOR GENE HOMOLOG MSH2 AND ITS ASSOCIATION WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
FISHEL, R ;
LESCOE, MK ;
RAO, MRS ;
COPELAND, NG ;
JENKINS, NA ;
GARBER, J ;
KANE, M ;
KOLODNER, R .
CELL, 1993, 75 (05) :1027-1038
[16]  
Gafà R, 2000, CANCER, V89, P2025, DOI 10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.0.CO
[17]  
2-S
[18]   Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer [J].
Gryfe, R ;
Kim, H ;
Hsieh, ETK ;
Aronson, MD ;
Holowaty, EJ ;
Bull, SB ;
Redston, M ;
Gallinger, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (02) :69-77
[19]   Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer). [J].
Hampel, H ;
Frankel, WL ;
Martin, E ;
Arnold, M ;
Khanduja, K ;
Kuebler, P ;
Nakagawa, H ;
Sotamaa, K ;
Prior, TW ;
Westman, J ;
Panescu, J ;
Fix, D ;
Lockman, J ;
Comeras, I ;
de la Chapelle, A ;
Ellison, C ;
Melvin, S ;
Winston, J ;
Adeli, A ;
Burak, W ;
Chadwick, R ;
Elkhatib, I ;
Hemingway, T ;
Jamieson, K ;
Johnson, C ;
LaJeunesse, J ;
Liyanarachchi, S ;
Rangel, P ;
Soble, D ;
Walker, M ;
Wise, T ;
Zhang, Y ;
Schlanger, R ;
Aguilar, P ;
Hura, D ;
Keith, J ;
Kerner, B ;
Lavalle, G ;
Taylor, C ;
Vara, T ;
Zangmeister, J ;
DeVictor, S ;
Hines, L ;
Lindsey, M ;
Madhavan, J ;
Padmanabhan, A ;
Hamelberg, K ;
Niemann, T ;
Behrens, BC ;
Blair, SC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (18) :1851-1860
[20]   Microsatellite instability testing in colorectal carcinoma: Choice of markers affects sensitivity of detection of mismatch repair-deficient tumors [J].
Hatch, SB ;
Lightfoot, HM ;
Garwacki, CP ;
Moore, DT ;
Calvo, BF ;
Woosley, JT ;
Sciarrotta, J ;
Funkhouser, WK ;
Farber, RA .
CLINICAL CANCER RESEARCH, 2005, 11 (06) :2180-2187